Adriano Aguzzi, professor and director of the Institute of Neuropathology at the University of Zurich, has been awarded for his research into neurodegenerative diseases [...]
Synapsis Foundation – Alzheimer Research Switzerland ARS announces a competition for Research Grants and Career Development Awards. Deadline for submission of proposals is [...]
ETH Zurich is a partner in the European EIT Health Consortium. For 2018, three new projects with ETH participation will receive funding by the Consortium. In one of these [...]
Alzheimer’s Disease, stroke and depression are among the most serious brain diseases. Lifestyle choices play an important role in their etiology. The new book by Hans-Ruedi [...]
With the rapidly progressing development of therapies for Alzheimer’s Disease (AD) treatment, comes the need for sensitive diagnostics. Within the Oxford-McGill-ZNZ [...]
Professor Lawrence Rajendran receives the SCOR Young Researcher European Grand Prize for his innovative research on Alzheimer’s disease (AD). Rajendran of the Systems and [...]
BACE1, the enzyme involved in amyloid formation, is an important therapeutic target for Alzheimer’s Disease. Blocking BACE1 has, however, led to severe side effects. [...]
Dr. Maria Teresa Ferretti was awarded a three-year research grant from the Synapsis foundation to study the role of the immune system in Alzheimer’s disease. Together with [...]